Citius Pharmaceuticals, Inc.
CTXR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506251
No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Citius Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +3 vs. Q1 2025
- Shares held
- 928.8K
- +293.3K (+46.1%) vs. Q1 2025
- Total value
- $1.48M
- +$529.9K (+55.9%) vs. Q1 2025
- New holders
- 8
- 6 more added
- Sold out
- 5
- 6 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTXR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 42 | $822.4K |
| Q1 2026 | 38 | $896.9K |
| Q4 2025 | 39 | $1.34M |
| Q3 2025 | 34 | $773.2K |
| Q2 2025 | 31 | $1.48M |
| Q1 2025 | 28 | $947.2K |
| Q4 2024 | 30 | $2.43M |
| Q3 2024 | 58 | $11.8M |
| Q2 2024 | 72 | $17.9M |
| Q1 2024 | 73 | $24.2M |
| Q4 2023 | 74 | $20.3M |
| Q3 2023 | 74 | $17.1M |
| Q2 2023 | 75 | $30.4M |
| Q1 2023 | 56 | $16.9M |
| Q4 2022 | 54 | $11.2M |
| Q3 2022 | 57 | $16.6M |
| Q2 2022 | 60 | $14.0M |
| Q1 2022 | 76 | $43.2M |
| Q4 2021 | 77 | $37.6M |
| Q3 2021 | 71 | $51.1M |
| Q2 2021 | 74 | $87.6M |
| Q1 2021 | 39 | $19.3M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Citius Pharmaceuticals, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fairscale Capital, LLC | 42 | $58 | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 45 | $72 | 0.00% | +45 | New |
| Morgan Stanley | 60 | $95 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 80 | $127 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 107 | $170 | 0.00% | 00.0% | Unchanged |
| Smallwood Wealth Investment Management, LLC | 120 | $190 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 120 | $191 | 0.00% | −16−11.8% | Reduced |
| Princeton Global Asset Management LLC | 160 | $254 | 0.00% | 00.0% | Unchanged |
| Murphy & Mullick Capital Management Corp | 160 | $254 | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 226 | $359 | 0.00% | +226 | New |
| Bank of America Corp | 377 | $599 | 0.00% | +309+454.4% | Added |
| Luminist Capital LLC | 435 | $827 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 649 | $1.03K | 0.00% | −2,693−80.6% | Reduced |
| Advisor Group Holdings, Inc. | 1,687 | $2.68K | 0.00% | +160+10.5% | Added |
| SBI Securities Co., Ltd. | 4,018 | $6.39K | 0.00% | +1,750+77.2% | Added |
| Chelsea Counsel Co | 4,626 | $7.36K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 7,083 | $11.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 12,874 | $20.5K | 0.00% | +12,874 | New |
| Susquehanna International Group, LLP | 14,199 | $22.6K | 0.00% | +14,199 | New |
| Northern Trust Corp | 14,373 | $22.9K | 0.00% | −800−5.3% | Reduced |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 16,500 | $26.2K | 0.00% | +2,500+17.9% | Added |
| Arkadios Wealth Advisors | 20,000 | $31.8K | 0.00% | +10,000+100.0% | Added |
| XTX Topco Ltd | 20,146 | $32.0K | 0.00% | +20,146 | New |
| State Street Corp | 23,271 | $37.0K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 25,000 | $39.8K | 0.00% | +25,000 | New |
| BlackRock, Inc. | 69,851 | $111.1K | 0.00% | −2,376−3.3% | Reduced |
| Geode Capital Management, LLC | 76,095 | $121.0K | 0.00% | −13,180−14.8% | Reduced |
| Vanguard Group Inc | 80,103 | $127.4K | 0.00% | −177,528−68.9% | Reduced |
| Heights Capital Management, Inc | 159,898 | $254.2K | 0.08% | +159,898 | New |
| Cambridge Investment Research Advisors, Inc. | 183,534 | $292.0K | 0.00% | +183,534 | New |
| UBS Group AG | 192,927 | $306.8K | 0.00% | +125,712+187.0% | Added |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −60,983−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,410−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −966−100.0% | Sold out |
| Quent Capital, LLC | 0 | $0 | 0.00% | −108−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |